Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PILGRIM: Perioperative Insulin, GIK or GLP-1 Treatment in Type 2 Diabetes
NCT02036372Completed
- Sponsor
- University of Amsterdam
- Start
- Jan 2014
- Primary completion
- Jan 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised trial of liraglutide in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by University of Amsterdam. Primary endpoint: Median glucose. Started Jan 2014; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02036372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02036372.